speb/financial-data huggingface dataset:
NMR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3485283000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 512955000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Current Debt: 1221743000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1221743000000.00
NMR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3019940964.00
NMR income_statement (quarterly, 2025-09-30) — Diluted EPS: 30.49
NMR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 91978000000.00
NMR income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 8735000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 404405000000.00
NMR income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 195079000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 75965000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Gross PPE: 999388000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 82289000000.00
NMR income_statement (quarterly, 2025-09-30) — Interest Expense: 645751000000.00
NMR income_statement (quarterly, 2025-09-30) — Interest Income: 652830000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 19483456000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 16176355000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 163701000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 14776430000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 14940131000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 691629000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Minority Interest: 123376000000.00
NMR income_statement (quarterly, 2025-09-30) — Minority Interests: -3715000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Net Debt: 9166338000000.00
NMR income_statement (quarterly, 2025-09-30) — Net Income: 92078000000.00
NMR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 92078000000.00
NMR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 95793000000.00
NMR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 92078000000.00
NMR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 92078000000.00
NMR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 95793000000.00
NMR income_statement (quarterly, 2025-09-30) — Net Interest Income: 7079000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Net PPE: 442280000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3409318000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 124414000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 124414000000.00
NMR income_statement (quarterly, 2025-09-30) — Normalized Income: 92078000000.00
NMR income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 17283000000.00
NMR income_statement (quarterly, 2025-09-30) — Operating Revenue: 468271000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2933610441.00
NMR balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1221743000000.00
NMR income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 174731000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Other Payable: 2763954000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1304514000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Payables: 4901136000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 5414091000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 30635000000.00
NMR income_statement (quarterly, 2025-09-30) — Pretax Income: 136645000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Receivables: 1747643000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1975904000000.00
NMR income_statement (quarterly, 2025-09-30) — Salaries And Wages: 195079000000.00
NMR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 195079000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Share Issued: 3163562601.00
NMR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3485283000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3409318000000.00
NMR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
NMR income_statement (quarterly, 2025-09-30) — Tax Provision: 40852000000.00
NMR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
NMR balance_sheet (quarterly, 2025-09-30) — Total Assets: 60367700000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 18261713000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Total Debt: 16161874000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3608659000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 56759041000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 82289000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Trading Securities: 14418308000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 229952160.00
NMR balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 171487000000.00
NMR income_statement (quarterly, 2025-12-31) — +Total Revenue: 497758000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1515387000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 398100000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -585807000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 694527000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 818033000000.00
NMR income_statement (quarterly, 2025-12-31) — Basic Average Shares: 2933450817.00
NMR income_statement (quarterly, 2025-12-31) — Basic EPS: 31.21
NMR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 594493000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5996817000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 19943397000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Cash Financial: 4905870000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Common Stock: 594493000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3651817000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Current Debt: 1314714000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1314714000000.00
NMR income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3032560450.00
NMR income_statement (quarterly, 2025-12-31) — Diluted EPS: 30.19
NMR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 91553000000.00
NMR income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 6052000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 466744000000.00
NMR income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 220739000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1102059000000.00
NMR income_statement (quarterly, 2025-12-31) — Interest Expense: 676173000000.00
NMR income_statement (quarterly, 2025-12-31) — Interest Income: 712469000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 20249296000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 27085147000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 15282765000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 15282765000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 734737000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Minority Interest: 162775000000.00
NMR income_statement (quarterly, 2025-12-31) — Minority Interests: -2993000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Net Debt: 10600662000000.00
NMR income_statement (quarterly, 2025-12-31) — Net Income: 91553000000.00
NMR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 91553000000.00
NMR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 94546000000.00
NMR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 91553000000.00
NMR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 91553000000.00
NMR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 94546000000.00
NMR income_statement (quarterly, 2025-12-31) — Net Interest Income: 36296000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Net PPE: 516252000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3651817000000.00
NMR income_statement (quarterly, 2025-12-31) — Normalized Income: 91553000000.00
NMR income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 17853000000.00
NMR income_statement (quarterly, 2025-12-31) — Operating Revenue: 497758000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2933854900.00
NMR balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1314714000000.00
NMR income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 123945000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Other Payable: 3556722000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Other Receivables: 960327000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Payables: 5072109000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 5072109000000.00
NMR income_statement (quarterly, 2025-12-31) — Pretax Income: 135221000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Receivables: 1358427000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 2067359000000.00
NMR income_statement (quarterly, 2025-12-31) — Salaries And Wages: 220739000000.00
NMR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 220739000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Share Issued: 3163562601.00
NMR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3651817000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3651817000000.00
NMR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NMR income_statement (quarterly, 2025-12-31) — Tax Provision: 40675000000.00
NMR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
NMR balance_sheet (quarterly, 2025-12-31) — Total Assets: 61935173000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 18934582000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Total Debt: 16597479000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3814592000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 58120581000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Trading Securities: 25532377000000.00
NMR balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 229707701.00
NMR balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 171306000000.00
NMR income_statement (annual, 2026-03-31) — +Total Revenue: 1841954000000.00
NMR income_statement (quarterly, 2026-03-31) — +Total Revenue: 397388000000.00
NMR balance_sheet (annual, 2026-03-31) — Accounts Payable: 1598758000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1598758000000.00
NMR balance_sheet (annual, 2026-03-31) — Accounts Receivable: 470341000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 470341000000.00
NMR balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -600417000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -600417000000.00
NMR balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 706261000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 706261000000.00
NMR balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1270394000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1270394000000.00
NMR income_statement (annual, 2026-03-31) — Average Dilution Earnings: -258000000.00
NMR income_statement (annual, 2026-03-31) — Basic Average Shares: 2942280410.00
NMR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2923408462.00
NMR income_statement (annual, 2026-03-31) — Basic EPS: 123.08
NMR income_statement (quarterly, 2026-03-31) — Basic EPS: 25.29
NMR cash_flow (annual, 2026-03-31) — Beginning Cash Position: 4425441000000.00
NMR cash_flow (annual, 2026-03-31) — Capital Expenditure: -353818000000.00
NMR balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 156279000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 156279000000.00
NMR balance_sheet (annual, 2026-03-31) — Capital Stock: 594493000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 594493000000.00
NMR balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 5648974000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5648974000000.00
NMR balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 18859210000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 18859210000000.00
NMR cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -179742000000.00
NMR balance_sheet (annual, 2026-03-31) — Cash Financial: 4298693000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Cash Financial: 4298693000000.00
NMR cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2095851000000.00
NMR cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1498923000000.00
NMR cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: -842960000000.00
NMR cash_flow (annual, 2026-03-31) — Change In Accrued Expense: 63422000000.00
NMR cash_flow (annual, 2026-03-31) — Change In Income Tax Payable: 25684000000.00
NMR cash_flow (annual, 2026-03-31) — Change In Other Working Capital: -1001612000000.00
NMR cash_flow (annual, 2026-03-31) — Change In Payable: 729306000000.00
NMR cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 792728000000.00
NMR cash_flow (annual, 2026-03-31) — Change In Tax Payable: 25684000000.00
NMR cash_flow (annual, 2026-03-31) — Change In Working Capital: -1303231000000.00
NMR cash_flow (annual, 2026-03-31) — Changes In Cash: -246032000000.00
NMR balance_sheet (annual, 2026-03-31) — Commercial Paper: 90795000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Commercial Paper: 90795000000.00
NMR balance_sheet (annual, 2026-03-31) — Common Stock: 594493000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Common Stock: 594493000000.00
NMR cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -179742000000.00
NMR balance_sheet (annual, 2026-03-31) — Common Stock Equity: 3707868000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3707868000000.00
NMR cash_flow (annual, 2026-03-31) — Common Stock Issuance: 422000000.00
NMR cash_flow (annual, 2026-03-31) — Common Stock Payments: -101499000000.00
NMR balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 700592000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 700592000000.00
NMR balance_sheet (annual, 2026-03-31) — Current Debt: 1752669000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Current Debt: 1752669000000.00
NMR balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1752669000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1752669000000.00
NMR cash_flow (annual, 2026-03-31) — Deferred Income Tax: 8349000000.00
NMR cash_flow (annual, 2026-03-31) — Deferred Tax: 8349000000.00
NMR cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 68269000000.00
NMR cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 68269000000.00
NMR income_statement (annual, 2026-03-31) — Diluted Average Shares: 3041190068.00
NMR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3037510271.00
NMR income_statement (annual, 2026-03-31) — Diluted EPS: 118.99
NMR income_statement (quarterly, 2026-03-31) — Diluted EPS: 24.34
NMR income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 361871000000.00
NMR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 73675000000.00
NMR cash_flow (annual, 2026-03-31) — Earnings Losses From Equity Investments: -18662000000.00
NMR cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 139313000000.00
NMR cash_flow (annual, 2026-03-31) — End Cash Position: 4318722000000.00
NMR cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2095851000000.00
NMR cash_flow (annual, 2026-03-31) — Free Cash Flow: -1196778000000.00
NMR cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -13066000000.00
NMR cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: 11995000000.00
NMR cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -58744000000.00
NMR income_statement (annual, 2026-03-31) — Gain On Sale Of Business: -11995000000.00
NMR income_statement (annual, 2026-03-31) — Gain On Sale Of Security: 25670000000.00
NMR income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 4930000000.00
NMR balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 548221000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 548221000000.00
NMR income_statement (annual, 2026-03-31) — General And Administrative Expense: 829502000000.00
NMR income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 227374000000.00
NMR balance_sheet (annual, 2026-03-31) — Goodwill: 172492000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Goodwill: 172492000000.00
NMR balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 315379000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 315379000000.00
NMR balance_sheet (annual, 2026-03-31) — Gross PPE: 1144264000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1144264000000.00
NMR cash_flow (annual, 2026-03-31) — Income Tax Paid Supplemental Data: 118852000000.00
NMR balance_sheet (annual, 2026-03-31) — Income Tax Payable: 105154000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 105154000000.00
NMR income_statement (annual, 2026-03-31) — Interest Expense: 2590773000000.00
NMR income_statement (quarterly, 2026-03-31) — Interest Expense: 635576000000.00
NMR income_statement (annual, 2026-03-31) — Interest Income: 2669640000000.00
NMR income_statement (quarterly, 2026-03-31) — Interest Income: 654780000000.00
NMR cash_flow (annual, 2026-03-31) — Interest Paid Supplemental Data: 2570408000000.00
NMR balance_sheet (annual, 2026-03-31) — Invested Capital: 21389649000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 21389649000000.00
NMR cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1498923000000.00
NMR balance_sheet (annual, 2026-03-31) — Investments And Advances: 17242004000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 17242004000000.00
NMR cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 422000000.00
NMR cash_flow (annual, 2026-03-31) — Issuance Of Debt: 7523928000000.00
NMR balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 156279000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 156279000000.00
NMR balance_sheet (annual, 2026-03-31) — Long Term Debt: 15929112000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 15929112000000.00
NMR balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 16085391000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 16085391000000.00
NMR cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 5055065000000.00
NMR cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -3181835000000.00
NMR balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 743497000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 743497000000.00
NMR balance_sheet (annual, 2026-03-31) — Minority Interest: 147047000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Minority Interest: 147047000000.00
NMR income_statement (annual, 2026-03-31) — Minority Interests: -12253000000.00
NMR income_statement (quarterly, 2026-03-31) — Minority Interests: -2636000000.00
NMR cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -275002000000.00
NMR cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: -101077000000.00
NMR balance_sheet (annual, 2026-03-31) — Net Debt: 12032807000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Net Debt: 12032807000000.00
NMR income_statement (annual, 2026-03-31) — Net Income: 362129000000.00
NMR income_statement (quarterly, 2026-03-31) — Net Income: 73933000000.00
NMR income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 362129000000.00
NMR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 73933000000.00
NMR income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 374382000000.00
NMR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 76569000000.00
NMR income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 362129000000.00
NMR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 73933000000.00
NMR income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 362129000000.00
NMR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 73933000000.00
NMR cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 374382000000.00
NMR income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 374382000000.00
NMR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 76569000000.00
NMR income_statement (annual, 2026-03-31) — Net Interest Income: 78867000000.00
NMR income_statement (quarterly, 2026-03-31) — Net Interest Income: 19204000000.00
NMR cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -277925000000.00
NMR cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 1983870000000.00
NMR cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 1873230000000.00
NMR cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 5423000000.00
NMR cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -20015000000.00
NMR balance_sheet (annual, 2026-03-31) — Net PPE: 543847000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Net PPE: 543847000000.00
NMR cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -119125000000.00
NMR cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 110640000000.00
NMR balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 3392489000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3392489000000.00
NMR balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 146706000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 146706000000.00
NMR balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 146706000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 146706000000.00
NMR income_statement (annual, 2026-03-31) — Normalized Income: 333238474000.00
NMR income_statement (quarterly, 2026-03-31) — Normalized Income: 73933000000.00
NMR income_statement (annual, 2026-03-31) — Occupancy And Equipment: 71523000000.00
NMR income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 20422000000.00
NMR cash_flow (annual, 2026-03-31) — Operating Cash Flow: -842960000000.00
NMR cash_flow (annual, 2026-03-31) — Operating Gains Losses: -78477000000.00
NMR income_statement (annual, 2026-03-31) — Operating Revenue: 1841954000000.00
NMR income_statement (quarterly, 2026-03-31) — Operating Revenue: 397388000000.00
NMR balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 2901337224.00
NMR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 2901337224.00
NMR balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 1661874000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1661874000000.00
NMR balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 142887000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 142887000000.00
NMR cash_flow (annual, 2026-03-31) — Other Non Cash Items: 46664000000.00
NMR income_statement (annual, 2026-03-31) — Other Non Interest Expense: 487895000000.00
NMR income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 128706000000.00
NMR balance_sheet (annual, 2026-03-31) — Other Payable: 3432040000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Other Payable: 3432040000000.00
NMR balance_sheet (annual, 2026-03-31) — Other Receivables: 1536600000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1536600000000.00
NMR income_statement (annual, 2026-03-31) — Other Special Charges: -58744000000.00
NMR balance_sheet (annual, 2026-03-31) — Payables: 5135952000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Payables: 5135952000000.00
NMR balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 5836544000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 5836544000000.00
NMR balance_sheet (annual, 2026-03-31) — Prepaid Assets: 34097000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 34097000000.00
NMR income_statement (annual, 2026-03-31) — Pretax Income: 539821000000.00
NMR income_statement (quarterly, 2026-03-31) — Pretax Income: 107673000000.00
NMR cash_flow (annual, 2026-03-31) — Purchase Of Business: -275014000000.00
NMR cash_flow (annual, 2026-03-31) — Purchase Of Investment: -530085000000.00
NMR cash_flow (annual, 2026-03-31) — Purchase Of PPE: -353818000000.00
NMR balance_sheet (annual, 2026-03-31) — Receivables: 2006941000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Receivables: 2006941000000.00
NMR income_statement (annual, 2026-03-31) — Reconciled Depreciation: 68269000000.00
NMR cash_flow (annual, 2026-03-31) — Repayment Of Debt: -5540058000000.00
NMR cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -101499000000.00
NMR income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 5120000000.00
NMR balance_sheet (annual, 2026-03-31) — Retained Earnings: 2013986000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2013986000000.00
NMR income_statement (annual, 2026-03-31) — Salaries And Wages: 829502000000.00
NMR income_statement (quarterly, 2026-03-31) — Salaries And Wages: 227374000000.00
NMR cash_flow (annual, 2026-03-31) — Sale Of Business: 12000000.00
NMR cash_flow (annual, 2026-03-31) — Sale Of Investment: 252160000000.00
NMR cash_flow (annual, 2026-03-31) — Sale Of PPE: 234693000000.00
NMR income_statement (annual, 2026-03-31) — Selling General And Administration: 829502000000.00
NMR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 227374000000.00
NMR balance_sheet (annual, 2026-03-31) — Share Issued: 3088562601.00
NMR balance_sheet (quarterly, 2026-03-31) — Share Issued: 3088562601.00
NMR cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 2468863000000.00
NMR cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -2358223000000.00
NMR income_statement (annual, 2026-03-31) — Special Income Charges: 41629000000.00
NMR cash_flow (annual, 2026-03-31) — Stock Based Compensation: 40836000000.00
NMR balance_sheet (annual, 2026-03-31) — Stockholders Equity: 3707868000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3707868000000.00
NMR balance_sheet (annual, 2026-03-31) — Tangible Book Value: 3392489000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3392489000000.00
NMR income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 12738474000.00
NMR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NMR income_statement (annual, 2026-03-31) — Tax Provision: 165439000000.00
NMR income_statement (quarterly, 2026-03-31) — Tax Provision: 31104000000.00
NMR income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.31
NMR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
NMR balance_sheet (annual, 2026-03-31) — Total Assets: 62645925000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Total Assets: 62645925000000.00
NMR balance_sheet (annual, 2026-03-31) — Total Capitalization: 19636980000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 19636980000000.00
NMR balance_sheet (annual, 2026-03-31) — Total Debt: 17838060000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Total Debt: 17838060000000.00
NMR balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 3854915000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3854915000000.00
NMR balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 58791010000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 58791010000000.00
NMR balance_sheet (annual, 2026-03-31) — Total Tax Payable: 105154000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 105154000000.00
NMR income_statement (annual, 2026-03-31) — Total Unusual Items: 41629000000.00
NMR income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 41629000000.00
NMR balance_sheet (annual, 2026-03-31) — Trading Securities: 15228113000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Trading Securities: 15228113000000.00
NMR balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 187225377.00
NMR balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 187225377.00
NMR balance_sheet (annual, 2026-03-31) — Treasury Stock: 155093000000.00
NMR balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 155093000000.00
NMR.AX income_statement (annual, 2021-06-30) — +Operating Expense: 3666375.00
NMR.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 38342.00
NMR.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -7582.00
NMR.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 5438.00
NMR.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -44703.00
NMR.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 6313727.00
NMR.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 2049092.00
NMR.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 2049092.00
NMR.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 2049092.00
NMR.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 5285862.00
NMR.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -44703.00
NMR.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3197505.00
NMR.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 2043654.00
NMR.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -3198828.00
NMR.AX balance_sheet (annual, 2021-06-30) — Common Stock: 6313727.00
NMR.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 2002439.00
NMR.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 5752700.00
NMR.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -466838.00
NMR.AX balance_sheet (annual, 2021-06-30) — Current Assets: 2107455.00
NMR.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 142137.00
NMR.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 7581.00
NMR.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 7581.00
NMR.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 7581.00
NMR.AX income_statement (annual, 2021-06-30) — EBIT: -3664781.00
NMR.AX income_statement (annual, 2021-06-30) — EBITDA: -3657200.00
NMR.AX cash_flow (annual, 2021-06-30) — End Cash Position: 2049092.00
NMR.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 5285862.00
NMR.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -3242208.00
NMR.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: 352990.00
NMR.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 811254.00
NMR.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 44703.00
NMR.AX income_statement (annual, 2021-06-30) — Interest Expense: 1629.00
NMR.AX income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 1629.00
NMR.AX income_statement (annual, 2021-06-30) — Interest Income: 1323.00
NMR.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 1323.00
NMR.AX cash_flow (annual, 2021-06-30) — Interest Received Direct: 1323.00
NMR.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 2002439.00
NMR.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -44703.00
NMR.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 5752700.00
NMR.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 44703.00
NMR.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 5285862.00
NMR.AX income_statement (annual, 2021-06-30) — Net Income: -3666410.00
NMR.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -3666410.00
NMR.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -3666410.00
NMR.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -3666410.00
NMR.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -3666410.00
NMR.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -3666410.00
NMR.AX income_statement (annual, 2021-06-30) — Net Interest Income: -306.00
NMR.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -306.00
NMR.AX balance_sheet (annual, 2021-06-30) — Net PPE: 37121.00
NMR.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -44703.00
NMR.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 2002439.00
NMR.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -3657200.00
NMR.AX income_statement (annual, 2021-06-30) — Normalized Income: -3666410.00
NMR.AX income_statement (annual, 2021-06-30) — Operating Income: -3666375.00
NMR.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 89914072.00
NMR.AX cash_flow (annual, 2021-06-30) — Other Cash Paymentsfrom Operating Activities: -1694949.00
NMR.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: 352990.00
NMR.AX income_statement (annual, 2021-06-30) — Other Income Expense: 271.00
NMR.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 271.00
NMR.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 2847540.00
NMR.AX balance_sheet (annual, 2021-06-30) — Other Payable: 64333.00
NMR.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 36600.00
NMR.AX balance_sheet (annual, 2021-06-30) — Payables: 102675.00
NMR.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 102675.00
NMR.AX cash_flow (annual, 2021-06-30) — Paymentsto Suppliersfor Goodsand Services: -1503879.00
NMR.AX balance_sheet (annual, 2021-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 39462.00
NMR.AX balance_sheet (annual, 2021-06-30) — Prepaid Assets: 21763.00
NMR.AX income_statement (annual, 2021-06-30) — Pretax Income: -3666410.00
NMR.AX cash_flow (annual, 2021-06-30) — Purchase Of PPE: -44703.00
NMR.AX balance_sheet (annual, 2021-06-30) — Receivables: 36600.00
NMR.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 7581.00
NMR.AX cash_flow (annual, 2021-06-30) — Repurchase Of Capital Stock: -466838.00
NMR.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -4664278.00
NMR.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 811254.00
NMR.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 811254.00
NMR.AX balance_sheet (annual, 2021-06-30) — Share Issued: 89914072.00
NMR.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: 2002439.00
NMR.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: 2002439.00
NMR.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
NMR.AX income_statement (annual, 2021-06-30) — Tax Provision: 0.00
NMR.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
NMR.AX balance_sheet (annual, 2021-06-30) — Total Assets: 2144576.00
NMR.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 2002439.00
NMR.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 2002439.00
NMR.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 142137.00
NMR.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 37121.00
NMR.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
NMR.AX balance_sheet (annual, 2021-06-30) — Working Capital: 1965318.00
NMR.AX income_statement (annual, 2022-06-30) — +Operating Expense: 4798800.00
NMR.AX income_statement (annual, 2022-06-30) — +Total Revenue: 30667.00
NMR.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 67775.00
NMR.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 739.00
NMR.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -45486.00
NMR.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 95339849.00
NMR.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.05
NMR.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 2049092.00
NMR.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -165173.00
NMR.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 9268187.00
NMR.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 449962.00
NMR.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 449962.00
NMR.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 449962.00
NMR.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 2935710.00
NMR.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: 12765.00
NMR.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -4547605.00
NMR.AX cash_flow (annual, 2022-06-30) — Changes In Cash: -1599130.00
NMR.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -4693976.00
NMR.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 146083.00
NMR.AX balance_sheet (annual, 2022-06-30) — Common Stock: 9268187.00
NMR.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 498044.00
NMR.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 3000797.00
NMR.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -65087.00
NMR.AX income_statement (annual, 2022-06-30) — Cost Of Revenue: 146982.00
NMR.AX balance_sheet (annual, 2022-06-30) — Current Assets: 559580.00
NMR.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 225926.00
NMR.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 37904.00
NMR.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 37904.00
NMR.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 37904.00
NMR.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 95339849.00
NMR.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.05
NMR.AX income_statement (annual, 2022-06-30) — EBIT: -4598672.00
NMR.AX income_statement (annual, 2022-06-30) — EBITDA: -4560768.00
NMR.AX cash_flow (annual, 2022-06-30) — End Cash Position: 449962.00
NMR.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 2935710.00
NMR.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -4712778.00
NMR.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 495040.00
NMR.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 1681865.00
NMR.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 209876.00
NMR.AX income_statement (annual, 2022-06-30) — Gross Profit: -116315.00
NMR.AX income_statement (annual, 2022-06-30) — Interest Expense: 2783.00
NMR.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 2783.00
NMR.AX income_statement (annual, 2022-06-30) — Interest Income: 288.00
NMR.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 288.00
NMR.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 288.00
NMR.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 498044.00
NMR.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: 12765.00
NMR.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 3000797.00
NMR.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 191713.00
NMR.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 2935710.00
NMR.AX income_statement (annual, 2022-06-30) — Net Income: -4601455.00
NMR.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -4601455.00
NMR.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -4601455.00
NMR.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -4601455.00
NMR.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -4601455.00
NMR.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -4601455.00
NMR.AX income_statement (annual, 2022-06-30) — Net Interest Income: -2495.00
NMR.AX cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: 177938.00
NMR.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -2495.00
NMR.AX balance_sheet (annual, 2022-06-30) — Net PPE: 164390.00
NMR.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -165173.00
NMR.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 498044.00
NMR.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -4560768.00
NMR.AX income_statement (annual, 2022-06-30) — Normalized Income: -4601455.00
NMR.AX income_statement (annual, 2022-06-30) — Operating Income: -4915115.00
NMR.AX income_statement (annual, 2022-06-30) — Operating Revenue: 30667.00
NMR.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 101856746.00
NMR.AX cash_flow (annual, 2022-06-30) — Other Cash Paymentsfrom Operating Activities: -3114004.00
NMR.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: 81155.00
NMR.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 495040.00
NMR.AX income_statement (annual, 2022-06-30) — Other Income Expense: 316155.00
NMR.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 316155.00
NMR.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 3079031.00
NMR.AX balance_sheet (annual, 2022-06-30) — Other Payable: 91218.00
NMR.AX balance_sheet (annual, 2022-06-30) — Other Properties: 18163.00
NMR.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 89188.00
NMR.AX balance_sheet (annual, 2022-06-30) — Payables: 158993.00
NMR.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 158993.00
NMR.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -1579972.00
NMR.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 66933.00
NMR.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 19691.00
NMR.AX income_statement (annual, 2022-06-30) — Pretax Income: -4601455.00
NMR.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -165173.00
NMR.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 64928.00
NMR.AX balance_sheet (annual, 2022-06-30) — Receivables: 89927.00
NMR.AX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 146982.00
NMR.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 37904.00
NMR.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -65087.00
NMR.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -9265183.00
NMR.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 1681865.00
NMR.AX cash_flow (annual, 2022-06-30) — Sale Of Investment: 177938.00
NMR.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 1681865.00
NMR.AX balance_sheet (annual, 2022-06-30) — Share Issued: 101856746.00
NMR.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 498044.00
NMR.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 498044.00
NMR.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
NMR.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
NMR.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
NMR.AX balance_sheet (annual, 2022-06-30) — Total Assets: 723970.00
NMR.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 498044.00
NMR.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 498044.00
NMR.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 225926.00
NMR.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 164390.00
NMR.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
NMR.AX balance_sheet (annual, 2022-06-30) — Working Capital: 333654.00
NMR.AX income_statement (annual, 2023-06-30) — +Operating Expense: 4134766.00
NMR.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 38674.00
NMR.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -89952.00
NMR.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 113306870.00
NMR.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.03
NMR.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 449962.00
NMR.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -26280.00
NMR.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 12541979.00
NMR.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 306837.00
NMR.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 306837.00
NMR.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 306837.00
NMR.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 3308875.00
NMR.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -26280.00
NMR.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3425720.00
NMR.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -143125.00
NMR.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -3851794.00
NMR.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 425547.00
NMR.AX balance_sheet (annual, 2023-06-30) — Common Stock: 12541979.00
NMR.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 194703.00
NMR.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 3381377.00
NMR.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -72502.00
NMR.AX balance_sheet (annual, 2023-06-30) — Current Assets: 419769.00
NMR.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 371268.00
NMR.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 44467.00
NMR.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 44467.00
NMR.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 44467.00
NMR.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 113306870.00
NMR.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.03
NMR.AX income_statement (annual, 2023-06-30) — EBIT: -3726528.00